Vimarsana
Biggest News Aggregation in the World

Cysview Hexvix News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cysview Hexvix. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cysview Hexvix Today - Breaking & Trending Today

Bladder Cancer: Long-Term Benefits of Blue Light Cystoscopy and Enhanced Detection with HD Technology Unveiled at AUA 2024 - Vimarsana News

Bladder Cancer: Long-Term Benefits of Blue Light Cystoscopy and Enhanced Detection with HD Technology Unveiled at AUA 2024

/PRNewswire/ -- Photocure ASA (OSE: PHO), the Bladder Cancer Company, announces its participation in the congress, and two abstract presentations at the AUA...

New Publication: Racial Difference in Detection Rate of Bladder Cancer Using Blue Light Cystoscopy -March 28, 2024 at 08:15 am EDT - Vimarsana News

New Publication: Racial Difference in Detection Rate of Bladder Cancer Using Blue Light Cystoscopy -March 28, 2024 at 08:15 am EDT

Press release - Oslo, Norway, March 28, 2024: Photocure ASA, The Bladder Cancer Company, announces the publication of the study Racial Difference in Detection Rate of Bladder Cancer Using Blue Light...

Photocure Partner Asieris announces New Drug Application acceptance for regulatory review of Hexvix in China - Vimarsana News

Photocure Partner Asieris announces New Drug Application acceptance for regulatory review of Hexvix in China

/PRNewswire/ -- Photocure ASA (OSE: PHO), the Bladder Cancer Company, announces that its partner Asieris Pharmaceuticals (SSE: 688176) communicated today that...

Photocure Partner Asieris to present first results for its Hexvix Phase III clinical trial in China at the SIU 2023 Annual Meeting - Vimarsana News

Photocure Partner Asieris to present first results for its Hexvix Phase III clinical trial in China at the SIU 2023 Annual Meeting

Press Release - Oslo, Norway, October 7, 2023: Photocure ASA , the Bladder Cancer Company, announces that its partner Asieris Pharmaceuticals has communicated its plan today to unveil the first...

New Health Economic analysis in France concludes there is insignificant cost difference between White Light and Blue Lig - Vimarsana News

New Health Economic analysis in France concludes there is insignificant cost difference between White Light and Blue Lig

OSLO, Norway, Oct. 6, 2023 /PRNewswire/ -- Photocure ASA, The Bladder Cancer Company, announces the...